Restless legs syndrome.
Autor(a) principal: | |
---|---|
Data de Publicação: | 2008 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/795 |
Resumo: | Restless legs syndrome (RLS) is a chronic sensorimotor disorder, with a negative impact in the quality of life and sleep architecture. Despite its reported high prevalence, remains under-recognized and under-treated. The diagnosis is based on the presence of four essential criteria, three supportive clinical features, and other three associated features. The primary or idiopathic RLS is the most common presentation form, but it is very important to exclude other RLS secondary forms and other differential diagnosis. The physiopathology of the idiopathic RLS remains unclear, however changes in the dopamine pathway have been proposed, and justifies the use of dopaminergic agents as first line treatment. Iron therapy, opioids, anti-epileptics (gabapentin) and benzodiazepines are others non-dopaminergic options of treatment in selected patients. |
id |
RCAP_f9ff415846e700216ec2b2aacdfb825b |
---|---|
oai_identifier_str |
oai:ojs.www.actamedicaportuguesa.com:article/795 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Restless legs syndrome.Síndrome de pernas inquietas.Restless legs syndrome (RLS) is a chronic sensorimotor disorder, with a negative impact in the quality of life and sleep architecture. Despite its reported high prevalence, remains under-recognized and under-treated. The diagnosis is based on the presence of four essential criteria, three supportive clinical features, and other three associated features. The primary or idiopathic RLS is the most common presentation form, but it is very important to exclude other RLS secondary forms and other differential diagnosis. The physiopathology of the idiopathic RLS remains unclear, however changes in the dopamine pathway have been proposed, and justifies the use of dopaminergic agents as first line treatment. Iron therapy, opioids, anti-epileptics (gabapentin) and benzodiazepines are others non-dopaminergic options of treatment in selected patients.Restless legs syndrome (RLS) is a chronic sensorimotor disorder, with a negative impact in the quality of life and sleep architecture. Despite its reported high prevalence, remains under-recognized and under-treated. The diagnosis is based on the presence of four essential criteria, three supportive clinical features, and other three associated features. The primary or idiopathic RLS is the most common presentation form, but it is very important to exclude other RLS secondary forms and other differential diagnosis. The physiopathology of the idiopathic RLS remains unclear, however changes in the dopamine pathway have been proposed, and justifies the use of dopaminergic agents as first line treatment. Iron therapy, opioids, anti-epileptics (gabapentin) and benzodiazepines are others non-dopaminergic options of treatment in selected patients.Ordem dos Médicos2008-10-24info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/795oai:ojs.www.actamedicaportuguesa.com:article/795Acta Médica Portuguesa; Vol. 21 No. 4 (2008): July-August; 359-66Acta Médica Portuguesa; Vol. 21 N.º 4 (2008): Julho-Agosto; 359-661646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/795https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/795/472Santos, BrunoOliveira, Ana SofiaCanhão, CristinaTeixeira, JoanaDias, Ana RitaPinto, PaulaBárbara, Cristinainfo:eu-repo/semantics/openAccess2022-12-20T10:56:57Zoai:ojs.www.actamedicaportuguesa.com:article/795Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:16:46.241354Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Restless legs syndrome. Síndrome de pernas inquietas. |
title |
Restless legs syndrome. |
spellingShingle |
Restless legs syndrome. Santos, Bruno |
title_short |
Restless legs syndrome. |
title_full |
Restless legs syndrome. |
title_fullStr |
Restless legs syndrome. |
title_full_unstemmed |
Restless legs syndrome. |
title_sort |
Restless legs syndrome. |
author |
Santos, Bruno |
author_facet |
Santos, Bruno Oliveira, Ana Sofia Canhão, Cristina Teixeira, Joana Dias, Ana Rita Pinto, Paula Bárbara, Cristina |
author_role |
author |
author2 |
Oliveira, Ana Sofia Canhão, Cristina Teixeira, Joana Dias, Ana Rita Pinto, Paula Bárbara, Cristina |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Santos, Bruno Oliveira, Ana Sofia Canhão, Cristina Teixeira, Joana Dias, Ana Rita Pinto, Paula Bárbara, Cristina |
description |
Restless legs syndrome (RLS) is a chronic sensorimotor disorder, with a negative impact in the quality of life and sleep architecture. Despite its reported high prevalence, remains under-recognized and under-treated. The diagnosis is based on the presence of four essential criteria, three supportive clinical features, and other three associated features. The primary or idiopathic RLS is the most common presentation form, but it is very important to exclude other RLS secondary forms and other differential diagnosis. The physiopathology of the idiopathic RLS remains unclear, however changes in the dopamine pathway have been proposed, and justifies the use of dopaminergic agents as first line treatment. Iron therapy, opioids, anti-epileptics (gabapentin) and benzodiazepines are others non-dopaminergic options of treatment in selected patients. |
publishDate |
2008 |
dc.date.none.fl_str_mv |
2008-10-24 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/795 oai:ojs.www.actamedicaportuguesa.com:article/795 |
url |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/795 |
identifier_str_mv |
oai:ojs.www.actamedicaportuguesa.com:article/795 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/795 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/795/472 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Ordem dos Médicos |
publisher.none.fl_str_mv |
Ordem dos Médicos |
dc.source.none.fl_str_mv |
Acta Médica Portuguesa; Vol. 21 No. 4 (2008): July-August; 359-66 Acta Médica Portuguesa; Vol. 21 N.º 4 (2008): Julho-Agosto; 359-66 1646-0758 0870-399X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130621518282752 |